Edition:
United States

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

3.50USD
20 Apr 2018
Change (% chg)

$-0.02 (-0.57%)
Prev Close
$3.52
Open
$3.50
Day's High
$3.59
Day's Low
$3.47
Volume
1,037
Avg. Vol
8,218
52-wk High
$5.25
52-wk Low
$2.37

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.215
Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 1 -0.16 -0.16 -0.16 --
Quarter Ending Sep-18 1 -0.17 -0.17 -0.17 --
Year Ending Dec-18 1 -0.69 -0.69 -0.69 -0.46
Year Ending Dec-19 1 -0.64 -0.64 -0.64 -0.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.01 33.60
P/E High - Last 5 Yrs. -- 40.51 45.95
P/E Low - Last 5 Yrs. -- 24.14 24.93
Beta -- 0.82 0.80
Price to Sales (TTM) -- 4.52 7.07
Price to Book (MRQ) 24.95 4.11 5.13
Price to Tangible Book (MRQ) -- 4.99 6.73
Price to Cash Flow (TTM) -- 22.60 25.52
% Owned Institutions 7.19 1.16 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.61 1.51
Dividend Yield - 5 Year Avg -- 0.72 0.75
Dividend 5 Year Growth Rate -- 2.72 3.93
Payout Ratio(TTM) -- 20.12 20.35

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.90 9.02
Sales (TTM) vs TTM 1 Yr. Ago -- 9.71 10.83
Sales - 5 Yr. Growth Rate -- 7.67 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 64.71 19.14 22.25
EPS (TTM) vs TTM 1 Yr. Ago 39.52 -- --
EPS - 5 Yr. Growth Rate -- 8.96 10.26
Capital Spending - 5 Yr. Growth Rate -- 9.66 10.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.53 2.53
Current Ratio (MRQ) 0.79 3.62 3.62
LT Debt to Equity (MRQ) 0.00 8.61 11.31
Total Debt to Equity (MRQ) 25.08 10.92 13.97
Interest Coverage (TTM) -1.18 35.68 30.11

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.62 54.01
Gross Margin - 5 Yr. Avg. -- 52.07 52.12
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.40 15.89
Operating Margin (TTM) -- 12.92 4.33
Operating Margin - 5 Yr. Avg. -- 14.20 11.25
Pre-Tax Margin (TTM) -- 13.17 4.97
Pre-Tax Margin - 5 Yr. Avg. -- 14.56 11.56
Net Profit Margin (TTM) -- 9.57 1.58
Net Profit Margin - 5 Yr. Avg. -- 10.88 7.89
Effective Tax Rate (TTM) -- 22.52 31.30
Effective Tax Rate - 5 Yr. Avg. -- 23.67 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 922,802,967 816,988,634
Net Income/Employee (TTM) -- 108,527,563 96,050,323
Receivable Turnover (TTM) -- 5.62 5.56
Inventory Turnover (TTM) -- 2.56 3.45
Asset Turnover (TTM) 0.00 0.92 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -181.41 10.96 10.54
Return on Assets - 5 Yr. Avg. -- 12.17 11.56
Return on Investment (TTM) -299.35 13.60 13.19
Return on Investment - 5 Yr. Avg. -- 15.72 14.97
Return on Equity (TTM) -455.37 15.26 15.00
Return on Equity - 5 Yr. Avg. -- 16.89 16.25
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 53.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.19%
# of Holders: 14
Total Shares Held: 903,950
3 Mo. Net Change: -985
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.